{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:38:19Z","timestamp":1763105899171,"version":"3.38.0"},"reference-count":0,"publisher":"JLE","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1684\/ejd.2022.4315","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T16:00:31Z","timestamp":1666886431000},"page":"546-548","source":"Crossref","is-referenced-by-count":3,"title":["Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors"],"prefix":"10.1684","volume":"32","member":"18929","container-title":["European Journal of Dermatology"],"original-title":[],"link":[{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2022.4315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:22:30Z","timestamp":1741191750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2022.4315"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1684\/ejd.2022.4315","relation":{},"ISSN":["1167-1122"],"issn-type":[{"type":"print","value":"1167-1122"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}